Muoio, J
ABSTRACT Glucagon-like peptide-1 (GLP-1) receptor agonists are efficacious glucose-lowering medications with salient benefits for body weight and cardiovascular events
Foundayo (orforglipron), another oral GLP-1 innovation, grants flexibility without the need for food or water restrictions
Importantly, patients should seek immediate medical attention for warning signs such as: Severe, persistent abdominal pain (possible pancreatitis) Right upper quadrant pain, fever, or jaundice (possible gallbladder disease) Severe, persistent vomiting or diarrhea leading to dehydration Signs of allergic reaction including rash, swelling, or difficulty breathing Unusual neck mass, difficulty swallowing, hoarseness, or shortness of breath (thyroid concerns) Maintaining open communication ensures accurate diagnosis, appropriate monitoring, and optimal therapeutic outcomes while taking this medication
I still ate foods I enjoyed
Adding these to your diet can help stabilize your digestion